News from boston scientific corporation A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

May 20, 2015, 02:31 ET

Post-Market Study Evaluating The Boston Scientific Lotus™ Valve System Demonstrates Extremely Low PVL Rates

A new study evaluating the Boston Scientific (NYSE: BSX) Lotus™ Valve System demonstrated an extremely low rate of paravalvular aortic...

May 12, 2015, 10:53 ET

Boston Scientific Completes $1.85 Billion Senior Notes Offering

 Boston Scientific Corporation (NYSE: BSX) completed a public offering of $1.85 billion aggregate principal amount of its senior notes under...

May 11, 2015, 09:24 ET

Boston Scientific Announces Scheduled Presentations at Heart Rhythm Society 2015

Boston Scientific (NYSE: BSX) today announced that key data from 42 abstracts will be featured at the 36th Annual Scientific Sessions of the...

May 07, 2015, 17:38 ET

Boston Scientific Prices $1.85 Billion Of Senior Notes

 Boston Scientific Corporation (NYSE: BSX) announced the pricing of a public offering of $1.85 billion aggregate principal amount of its senior...

May 01, 2015, 08:00 ET

Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day

 Boston Scientific Corporation (NYSE: BSX) is presenting an overview of its continued business momentum and long-term growth strategies at a...

Apr 28, 2015, 12:47 ET
http://www.multivu.com/players/English/7223454-boston-scientific-eluvia-stent/gallery/image/0bdeec48-e390-4e91-b48b-58bc5204f038.HR.jpg

New Data Evaluating The Boston Scientific Eluvia(TM) Drug-Eluting Vascular Stent System Demonstrate 94.4 Percent Primary Patency Rate At Nine Months

 In an important clinical advancement in the treatment of peripheral artery disease (PAD), a key trial evaluating the Boston Scientific (NYSE:...

Apr 28, 2015, 07:00 ET

Boston Scientific Announces Results for First Quarter 2015

 Boston Scientific Corporation (NYSE: BSX) generated sales of $1.768 billion during the first quarter ended March 31, 2015, compared to the...

Apr 27, 2015, 16:30 ET

Boston Scientific To Participate In The Bank Of America Merrill Lynch 2015 Healthcare Conference

 Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Bank of America Merrill Lynch 2015 Healthcare Conference on May...

Apr 27, 2015, 16:15 ET

Boston Scientific Announces Strategic Collaboration With Brainlab AG

Boston Scientific Corporation (NYSE: BSX) announces a collaboration with Brainlab AG, a leading software-driven medical technology company that...

Apr 24, 2015, 08:30 ET

Boston Scientific To Participate In The Deutsche Bank 40th Annual Healthcare Conference

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Deutsche Bank 40th Annual Healthcare Conference on May 6 in...

Apr 20, 2015, 16:01 ET

Long-Term Data Underscore Safety And Efficacy Of The Boston Scientific S-ICD™ System

Today the Journal of the American College of Cardiology published data confirming the long-term safety and efficacy of the Boston Scientific...

Apr 16, 2015, 16:05 ET
In the U.S., the Vessix™ Renal Denervation System is an investigational device, limited by applicable law to investigational use and not available for sale.

Boston Scientific Enrolls First Patient In New Study Designed To Demonstrate The Effect Of The Vessix™ Renal Denervation System

 Boston Scientific Corporation (NYSE: BSX) is taking a new approach to evaluate the performance of the Vessix™ Renal Denervation...

Apr 14, 2015, 09:00 ET

Boston Scientific Signs Strategic Alliance With Frankenman Medical Equipment Company

Boston Scientific Corporation (NYSE: BSX), a leading global medical device company, announced the signing of a strategic alliance with Frankenman...

Apr 01, 2015, 16:01 ET

Boston Scientific Agrees to Acquire Xlumena

 Boston Scientific Corporation (NYSE: BSX) announces that it has signed a definitive agreement to acquire Xlumena, Inc., a venture-backed...

Apr 01, 2015, 08:30 ET

Boston Scientific To Webcast Conference Call On First Quarter 2015 Financial Results

 Boston Scientific Corporation (NYSE: BSX) will webcast a conference call on Tuesday, April 28, 2015 at 8 a.m. ET to review financial results...

Mar 24, 2015, 16:01 ET

Boston Scientific Announces First U.S. Commercial Procedures With The WATCHMAN™ Left Atrial Appendage Closure Device

This week, four patients in the United States received the first implants of the Boston Scientific Corporation (NYSE: BSX) WATCHMAN™ Left...

Mar 17, 2015, 16:01 ET

Boston Scientific announces FDA and CE Mark Approval Of The EMBLEM™ S-ICD System

Boston Scientific Corporation (NYSE: BSX) has received FDA and CE Mark approval of the EMBLEM™ Subcutaneous Implantable Defibrillator (S-ICD)...

Mar 13, 2015, 18:54 ET

Boston Scientific Receives FDA Approval for WATCHMAN™ Left Atrial Appendage Closure Device

 Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the WATCHMAN Left Atrial Appendage...

Mar 03, 2015, 16:05 ET

Boston Scientific Elects Charles J. Dockendorff And Stephen P. MacMillan To Board Of Directors

Boston Scientific Corporation (NYSE: BSX) announces the election of Charles J. Dockendorff and Stephen P. MacMillan to its board of directors,...

Mar 02, 2015, 07:00 ET

Boston Scientific Announces Definitive Agreement To Acquire American Medical Systems' Urology Portfolio For Up To $1.65 Billion

Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement with Endo International plc (NASDAQ:...